Fernando Andreu (CEO) and Ole Thastrup (CSO) participation in “Life Science Investor Konference” 23. February 2022, Copenhagen, Denmark
Watch webcast
Events
2cureX Events
Mangold Insight Investerardag på tema Life Science – Mangold Fondkommission AB
Read more
2cureX presents at Redeye Theme – Fight Cancer Seminar – Outlook 2022 (Stockholm, Sweden)
Watch webcast
2cureX – Company Introduction by HC Andersen Capital
Watch webcast
2cureX presents at HC Andersen Capital’s Virtual Growth Days (Copenhagen, Denmark)
Watch webcast
CEO Fernando Andreu will present at ”Sedermeradagen Köbenhamn 2021” (Copenhagen, Denmark)
Read more
Webinar: Presentation of the Q3 report by CEO Fernando Andreu, CFO Kenneth G. Johansen and CSO Ole Thastrup
Watch webinar
Q3 2021 Interim Report released
View report
Presentation by Fernando Andreu (CEO) and Ole Thastrup (CSO) at the Investor-week by the Dansk Shareholder’s Association
Read more
Presentation by Ole Thastrup (CSO 2cureX) at the TechConnect Europe Innovation Conference & Expo (Malmø, Sweden)
Read more
Presentation by Henrik Harling (CMO 2cureX) at the 17. National Congress of Digestive Cancers (Viseu, Portugal)
Read more
2cureX at Redeye: Strategy Update
Watch webcast
Precision Oncology Webinar: Beyond Biomarkers. Clinical Peers (Dr. John Lindsay Marshall, from Georgetown University Hospital, US and Dr Jesús García-Foncillas, from University Hospital Fundación Jimenez Diaz, Madrid, Spain and Dr. Lars Henrik Jensen, University Hospital Vejle, DK) present the role of the functional test IndiTreat® in personalized oncology to oncologists and 2cureX’s Distributors (promoted on Oncology Convention website, UK. Open participation.
Watch webcast
Mangold Investor Lunch
Read more
Redeye Medtech & Diagnostics Investor meeting
Read more
CSO Ole Thastrup will speak at the conference “Week of Health and Innovation 2021” in Odense, Denmark
Read more
Interview with CEO Fernando Andreu (organized by Mangold) Open participation. Details provided later.
Read more
Strategy update Webinar. CSO Fernando Andreu, CSO Ole Thastrup, VP Business Development Pia van der Zee and VP Sales Jesper F. Kristiansen provide a strategy update to investors, analysts, and media.
Watch webcast